Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Foundation Synchrony News

Foundation Synchrony News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Foundation Synchrony. Real-time updates on events, politics, business and more.

Zynerba Pharmaceuticals Inc. announces clinical development updates for Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and developmental and epileptic encephalopathies

January 4, 2022
The company said it plans to focus on the development of its Zygel CBD gel on autism spectrum disorder and 22q11.2 deletion syndrome along...
Armando Anido Zynerba Pharmaceuticals Inc European Union European Medicines Agency Foundation Synchrony Drug Administration
Source: proactiveinvestors.com

STALICLA Translates its Novel Precision Medicine Approach for Autism Spectrum Disorder into Clinical Development with First Patient in Phase 1b Trial of STP1

December 10, 2020
(1) -First precision therapeutic to be investigated in a biologically defined ASD subpopulation: ASD-Phen1 discovered and clinically validated by STALICLA- -STP1 could provide a new therapeutic option for as many as 20% of patients with non-monogenetic causes of ASD- STALICLA SA, today announced first patient enrolled in its Phase 1b clinical trial with STP1, a first in class precision medicine for patients within the autism spectrum disorder (ASD) Phenotype 1 subgroup (ASD-Phen1), a novel ...
United States South Carolina Lynn Durham Kostenloser Wertpapierhandel Delphine Charvin Craig Erickson
Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science